Huadong Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 7, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	62,879	60,553	72,565	82,087	70,342	46,475
Market Cap Growth	5.03%	-16.55%	-11.60%	16.70%	51.35%	8.94%
Enterprise Value	61,146	58,711	70,923	81,583	69,341	46,024
Last Close Price	35.94	33.87	39.34	44.09	37.60	24.72
PE Ratio	17.07	17.24	25.56	32.85	30.56	16.48
Forward PE	17.24	19.83	27.57	30.39	29.34	13.64
PS Ratio	1.46	1.45	1.79	2.18	2.04	1.38
PB Ratio	2.57	2.57	3.36	4.28	4.15	3.06
P/TBV Ratio	3.60	3.67	4.50	5.92	5.76	3.98
P/FCF Ratio	31.91	29.96	31.24	69.06	29.92	23.98
P/OCF Ratio	16.32	16.15	18.47	34.46	22.19	13.62
PEG Ratio	-	1.27	1.27	1.27	1.27	1.27
EV/Sales Ratio	1.42	1.40	1.75	2.16	2.01	1.37
EV/EBITDA Ratio	11.45	11.53	16.43	21.60	20.91	13.32
EV/EBIT Ratio	13.64	13.53	19.76	25.86	24.71	15.22
EV/FCF Ratio	31.03	29.05	30.54	68.64	29.50	23.74
Debt / Equity Ratio	0.09	0.13	0.09	0.14	0.12	0.13
Debt / EBITDA Ratio	0.43	0.58	0.44	0.67	0.61	0.58
Debt / FCF Ratio	1.16	1.50	0.83	2.17	0.89	1.03
Net Debt / Equity Ratio	-0.09	-0.09	-0.13	-0.07	-0.11	-0.08
Net Debt / EBITDA Ratio	-0.40	-0.44	-0.63	-0.37	-0.59	-0.35
Net Debt / FCF Ratio	-1.06	-1.11	-1.17	-1.19	-0.83	-0.62
Asset Turnover	1.11	1.17	1.26	1.30	1.35	1.48
Inventory Turnover	5.64	6.18	6.25	6.07	5.96	5.57
Quick Ratio	1.16	1.15	1.28	1.23	1.21	1.19
Current Ratio	1.56	1.53	1.71	1.73	1.67	1.70
Return on Equity (ROE)	15.61%	15.48%	13.97%	14.02%	14.56%	20.75%
Return on Assets (ROA)	7.24%	7.60%	6.94%	6.78%	6.85%	8.28%
Return on Invested Capital (ROIC)	16.86%	17.55%	16.10%	16.09%	16.02%	19.22%
Return on Capital Employed (ROCE)	17.70%	18.00%	15.80%	15.00%	15.80%	19.40%
Earnings Yield	5.88%	5.80%	3.91%	3.04%	3.27%	6.07%
FCF Yield	3.13%	3.34%	3.20%	1.45%	3.34%	4.17%
Dividend Yield	2.56%	2.75%	1.47%	0.66%	0.77%	0.93%
Payout Ratio	46.05%	48.47%	20.93%	23.07%	19.99%	20.06%
Buyback Yield / Dilution	-0.26%	-0.08%	-0.10%	-0.00%	0.00%	-0.00%
Total Shareholder Return	2.30%	2.66%	1.37%	0.66%	0.78%	0.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.